Literature DB >> 27171512

Development and Potential Utility of a New Scoring Formula for Prediction of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas.

Yutaka Suzuki1, Tetsuya Nakazato, Masaaki Yokoyama, Masaharu Kogure, Ryota Matsuki, Nobutsugu Abe, Toshiyuki Mori, Yasuo Ohkura, Masanori Sugiyama.   

Abstract

OBJECTIVE: A simple system is needed to determine whether surgery is indicated in cases of intraductal papillary mucinous neoplasm (IPMN).
METHODS: We conducted a retrospective study to identify factors predictive of malignant IPMN and thus simplify the treatment decision-making process. Ninety-six consecutive patients treated surgically for IPMN at Kyorin University Hospital (Tokyo, Japan) between 1994 and 2014 were included. Univariate and multivariate analyses were used to identify preoperative factors predictive of malignancy. A simple scoring formula was derived from the regression equation.
RESULTS: Twenty-two (23%) of the IPMNs were malignant, and 74 (77%) were benign. Pancreatic head tumor, cyst diameter of 47 mm or greater, and mural nodule diameter of 9 mm or greater were identified as significant predictors of malignant IPMN. The following scoring formula was developed: 4 × tumor location (pancreatic head, 1; pancreatic body or tail, 0) + 3 × cyst diameter (≥47 mm, 1; <47 mm, 0) + 6 × mural nodule diameter (≥9 mm, 1; <9 mm, 0); the area under the receiver operating characteristic curve was 0.970. At a cutoff of 8 points, the diagnostic accuracy was excellent (sensitivity, 90.9%; specificity, 95.9%; accuracy, 94.8%).
CONCLUSIONS: Our scoring system has potential as a simple screening tool for the identification of malignant IPMN.

Entities:  

Mesh:

Year:  2016        PMID: 27171512     DOI: 10.1097/MPA.0000000000000649

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.

Authors:  Alba Manuel-Vázquez; Anita Balakrishnan; Paul Agami; Bodil Andersson; Frederik Berrevoet; Marc G Besselink; Ugo Boggi; Damiano Caputo; Alberto Carabias; Lucia Carrion-Alvarez; Carmen Cepeda Franco; Alessandro Coppola; Bobby V M Dasari; Sherley Diaz-Mercedes; Michail Feretis; Constantino Fondevila; Giuseppe Kito Fusai; Giuseppe Garcea; Victor Gonzabay; Miguel Ángel Gómez Bravo; Myrte Gorris; Bart Hendrikx; Camila Hidalgo-Salinas; Prashant Kadam; Dimitrios Karavias; Emanuele Kauffmann; Amar Kourdouli; Vincenzo La Vaccara; Stijn van Laarhoven; James Leighton; Mike S L Liem; Nikolaos Machairas; Dimitris Magouliotis; Adel Mahmoud; Marco V Marino; Marco Massani; Paola Melgar Requena; Keno Mentor; Niccolò Napoli; Jorieke H T Nijhuis; Andrej Nikov; Cristina Nistri; Victor Nunes; Eduardo Ortiz Ruiz; Sanjay Pandanaboyana; Baltasar Pérez Saborido; Radek Pohnán; Mariuca Popa; Belinda Sánchez Pérez; Francisco Sánchez Bueno; Alejandro Serrablo; Mario Serradilla-Martín; James R A Skipworth; Kjetil Soreide; Dimitris Symeonidis; Dimitris Zacharoulis; Piotr Zelga; Daniel Aliseda; María Jesús Castro Santiago; Carlos Fernández Mancilla; Raquel Latorre Fragua; Daniel Llwyd Hughes; Carmen Payá Llorente; Mickaël Lesurtel; Tom Gallagher; José Manuel Ramia
Journal:  Langenbecks Arch Surg       Date:  2022-10-06       Impact factor: 2.895

2.  Mucinous Pancreatic Cysts: Comparison of Cyst Size and Location in Certain Mucinous Cyst Subgroups.

Authors:  Ibrahim Hakki Köker; Şahende Elagöz; Zuhal Gücin; Fatma Ümit Malya; Hakan Şenturk
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

3.  Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.

Authors:  Min Sun; Liqing Kang; Yanchao Cui; Guoce Li
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

4.  Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression.

Authors:  Kasper A Overbeek; Maaike Alblas; Valerie Gausman; Pujan Kandel; Adam B Schweber; Christian Brooks; Priscilla A Van Riet; Michael B Wallace; Tamas A Gonda; Djuna L Cahen; Marco J Bruno
Journal:  Aliment Pharmacol Ther       Date:  2019-08-19       Impact factor: 8.171

5.  Risk stratification tools for branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Alberto Balduzzi; Roberto Salvia; Matthias Löhr
Journal:  United European Gastroenterol J       Date:  2022-02-05       Impact factor: 4.623

6.  International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression.

Authors:  Kasper A Overbeek; Nikki van Leeuwen; Matteo Tacelli; Muhammad S Anwar; Muhammad N Yousaf; Ankit Chhoda; Paolo Giorgio Arcidiacono; Tamas A Gonda; Michael B Wallace; Gabriele Capurso; James J Farrell; Djuna L Cahen; Marco J Bruno
Journal:  United European Gastroenterol J       Date:  2022-02-24       Impact factor: 4.623

Review 7.  Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas.

Authors:  M Heckler; L Brieger; U Heger; T Pausch; C Tjaden; J Kaiser; M Tanaka; T Hackert; C W Michalski
Journal:  BJS Open       Date:  2018-02-05

8.  The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm.

Authors:  Kazuya Miyamoto; Kazuyuki Matsumoto; Hironari Kato; Ryuichi Yoshida; Yuzo Umeda; Hirohumi Inoue; Takehiro Tanaka; Akihiro Matsumi; Yosuke Saragai; Yuki Fujii; Tatsuhiro Yamazaki; Daisuke Uchida; Takeshi Tomoda; Shigeru Horiguchi; Takahito Yagi; Hiroyuki Okada
Journal:  BMC Gastroenterol       Date:  2020-09-29       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.